Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

BACKGROUND: The Middle East respiratory syndrome coronavirus (MERS-CoV) has been reported to have a high case-fatality rate. Currently, there is no specific therapy or vaccine with proven effectiveness for MERS-CoV infections. METHODS: A combination of ribavirin and interferon therapy was used for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Tawfiq, Jaffar A., Momattin, Hisham, Dib, Jean, Memish, Ziad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110882/
https://www.ncbi.nlm.nih.gov/pubmed/24406736
http://dx.doi.org/10.1016/j.ijid.2013.12.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110882/
https://www.ncbi.nlm.nih.gov/pubmed/24406736
http://dx.doi.org/10.1016/j.ijid.2013.12.003

Ejemplares similares